Ligand id: 6933

Name: gantenerumab

No information available.
Summary of Clinical Use
May be useful in the treatment of Alzheimer's disease [3]. In phase I trials treatment caused reduced brain amyloid β levels, but was associated with the unwanted side effect of vasogenic edema. Phase III trial is underway with results expected in 2015.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT01760005 Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Phase 2/Phase 3 Interventional Washington University School of Medicine